SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.510
+0.010 (0.29%)
Sep 18, 2026, 4:00 PM EDT - Market closed
SAB Biotherapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| - | - | - | - | - | - | 0.11 | - | 0.26 | 0.94 | 0.31 | 1.27 | 0.09 | 0.58 | 2.16 | 3.59 | 6.35 | 11.8 | 11.06 | 14.68 | |
Revenue Growth (YoY) | - | - | - | - | - | - | -62.40% | - | 207.70% | 62.55% | -85.89% | -64.70% | -98.65% | -95.08% | -80.46% | -75.55% | -65.13% | -30.27% | -57.06% | -15.96% |
Cost of Revenue | 16.17 | 13.4 | 9.73 | 8.97 | 7 | 7.66 | 6.95 | 7.83 | 6.82 | 8.15 | 4.3 | 4.02 | 3.66 | 4.54 | 7.14 | 7.35 | 8.58 | 13.32 | 10.65 | 15.07 |
Gross Profit | -16.17 | -13.4 | -9.73 | -8.97 | -7 | -7.66 | -6.84 | -7.83 | -6.56 | -7.2 | -3.99 | -2.75 | -3.58 | -3.95 | -4.98 | -3.76 | -2.23 | -1.52 | 0.41 | -0.39 |
Selling, General & Admin | 7.21 | 6.6 | 6.04 | 3.71 | 2.74 | 3.11 | 3.17 | 3.48 | 3.64 | 4.19 | 14.88 | 2.57 | 2.9 | 3.45 | 2.88 | 4.04 | 4.31 | 5.19 | 7.75 | 3.6 |
Operating Expenses | 7.21 | 6.6 | 6.04 | 3.71 | 2.74 | 3.11 | 3.17 | 3.48 | 3.64 | 4.19 | 14.88 | 2.57 | 2.9 | 3.45 | 2.88 | 4.04 | 4.31 | 5.19 | 7.75 | 3.6 |
Operating Income | -23.38 | -20 | -15.77 | -12.68 | -9.73 | -10.77 | -10.01 | -11.31 | -10.2 | -11.39 | -18.87 | -5.32 | -6.48 | -7.4 | -7.86 | -7.81 | -6.54 | -6.71 | -7.34 | -3.99 |
Interest Expense | -0.06 | -0.06 | -0.06 | -0.04 | -0.06 | -0.07 | -0.07 | -0.08 | -0.09 | -0.08 | -0.08 | -0.07 | -0.08 | -0.09 | -0.09 | -0.07 | -0.07 | -0.07 | -0.07 | -0.08 |
Interest & Investment Income | 1.71 | 1.05 | 0.7 | 0.66 | 0.01 | 0.06 | 0.14 | 0.28 | 0.37 | 0.5 | 0.48 | 0.01 | 0.03 | 0.06 | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0 |
Other Non Operating Income (Expenses) | -0.76 | 0.14 | -1.73 | 57.51 | -0.33 | 5.58 | -1.45 | 0.76 | 2.58 | 5.94 | -4.39 | 0.28 | -0.36 | 0.08 | 0.02 | 0.78 | 1.73 | 7.85 | -4.15 | 0 |
EBT Excluding Unusual Items | -22.49 | -18.87 | -16.86 | 45.45 | -10.11 | -5.2 | -11.39 | -10.35 | -7.34 | -5.03 | -22.86 | -5.1 | -6.88 | -7.35 | -7.9 | -7.08 | -4.87 | 1.08 | -11.55 | -4.06 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.02 | - | - | - | - | - |
Other Unusual Items | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.03 | - | - | - | - | - |
Pretax Income | -22.49 | -18.87 | -16.86 | 45.45 | -10.11 | -5.2 | -11.39 | -10.35 | -7.34 | -5.03 | -22.86 | -5.1 | -6.88 | -7.35 | -7.85 | -7.08 | -4.87 | 1.08 | -11.55 | -4.06 |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.03 | - | -0.09 | 0.09 | - | - |
Net Income | -22.49 | -18.87 | -16.86 | 45.45 | -10.11 | -5.2 | -11.39 | -10.35 | -7.34 | -5.03 | -22.86 | -5.1 | -6.88 | -7.35 | -7.87 | -7.08 | -4.78 | 0.99 | -11.55 | -4.06 |
Preferred Dividends & Other Adjustments | - | - | -14.02 | 40.11 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -22.49 | -18.87 | -2.85 | 5.34 | -10.11 | -5.2 | -11.39 | -10.35 | -7.34 | -5.03 | -22.86 | -5.1 | -6.88 | -7.35 | -7.87 | -7.08 | -4.78 | 0.99 | -11.55 | -4.06 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -30.07% | - | - |
Shares Outstanding (Basic) | 80 | 54 | 48 | 11 | 9 | 9 | 9 | 9 | 9 | 9 | 7 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 3 | 3 |
Shares Outstanding (Diluted) | 80 | 54 | 48 | 78 | 9 | 9 | 9 | 9 | 9 | 9 | 7 | 5 | 5 | 5 | 4 | 4 | 4 | 5 | 3 | 3 |
Shares Change (YoY) | 758.07% | 476.42% | 416.56% | 740.93% | 0.43% | 0.54% | 37.44% | 76.68% | 83.55% | 83.38% | 50.33% | 21.79% | 17.26% | 10.00% | 43.06% | 65.67% | 65.55% | 63.21% | -10.73% | -56.64% |
EPS (Basic) | -0.28 | -0.35 | -0.06 | 0.50 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.38 | -0.97 | -1.36 | -1.46 | -1.75 | -1.64 | -1.11 | 0.23 | -3.67 | -1.56 |
EPS (Diluted) | -0.28 | -0.35 | -0.25 | -0.21 | -1.09 | -0.56 | -1.23 | -1.12 | -0.79 | -0.54 | -3.38 | -0.97 | -1.36 | -1.46 | -1.75 | -1.64 | -1.11 | 0.20 | -3.70 | -1.56 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -60.00% | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -11.43 | -15.25 | -17.71 | -13.05 | -7.15 | -7.8 | -9.59 | -6.39 | -7.77 | -10.88 | -13.51 | -5.25 | -4.92 | -1.63 | -1.67 | -8 | -5.06 | -10.9 | -7.24 | 0.57 |
Free Cash Flow Per Share | -0.14 | -0.28 | -0.37 | -0.17 | -0.77 | -0.84 | -1.03 | -0.69 | -0.84 | -1.18 | -2.00 | -1.00 | -0.98 | -0.32 | -0.37 | -1.86 | -1.18 | -2.38 | -2.30 | 0.22 |
Gross Margin | - | - | - | - | - | - | - | - | - | - | - | -217.17% | - | - | -230.34% | -104.83% | -35.18% | -12.89% | 3.71% | -2.65% |
Operating Margin | - | - | - | - | - | - | -8726.26% | - | -3876.95% | -1205.90% | -6187.90% | -420.00% | -7573.40% | -1273.79% | -363.74% | -217.49% | -103.03% | -56.83% | -66.41% | -27.18% |
Profit Margin | - | - | - | - | - | - | -9934.52% | - | -2787.69% | -532.06% | -7493.75% | -402.59% | -8046.13% | -1265.50% | -364.42% | -197.12% | -75.21% | 8.35% | -104.46% | -27.66% |
Free Cash Flow Margin | - | - | - | - | - | - | -8358.96% | - | -2952.95% | -1151.74% | -4430.85% | -414.49% | -5755.33% | -279.99% | -77.41% | -222.78% | -79.69% | -92.31% | -65.47% | 3.88% |
EBITDA | -22.54 | -19.25 | -15.01 | -11.91 | -8.96 | -9.99 | -9.22 | -10.34 | -9.15 | -9.41 | -17.93 | -4.34 | -5.58 | -6.48 | -6.84 | -6.92 | -5.79 | -6.07 | -6.72 | -3.62 |
EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -192.83% | -91.23% | -51.44% | -60.81% | -24.64% |
D&A For EBITDA | 0.83 | 0.75 | 0.76 | 0.77 | 0.77 | 0.78 | 0.79 | 0.97 | 1.06 | 1.98 | 0.94 | 0.99 | 0.89 | 0.92 | 1.02 | 0.89 | 0.75 | 0.64 | 0.62 | 0.37 |
EBIT | -23.38 | -20 | -15.77 | -12.68 | -9.73 | -10.77 | -10.01 | -11.31 | -10.2 | -11.39 | -18.87 | -5.32 | -6.48 | -7.4 | -7.86 | -7.81 | -6.54 | -6.71 | -7.34 | -3.99 |
EBIT Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -217.49% | -103.03% | -56.83% | -66.41% | -27.18% |
Effective Tax Rate | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.56% | - | - |
Revenue as Reported | - | - | - | - | - | - | 0.11 | - | 0.26 | 0.94 | 0.31 | 1.27 | 0.09 | 0.58 | 2.16 | 3.59 | 6.35 | 11.8 | 11.06 | 14.68 |